Bruna Chiari-Andréo

Prof. Bruna Chiari-Andréo

University of Araraquara, UNIARA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Bruna Lallo da SilvaBruna Lallo da Silva
Bruna Lallo da Silva
Marina Paiva AbuçafyMarina Paiva Abuçafy
Marina Paiva Abuçafy
EMEloisa Berbel Manaia
Eloisa Berbel Manaia
João Augusto Oshiro-JúniorJoão Augusto Oshiro-Júnior
João Augusto Oshiro-Júnior
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
LCLeila Chiavacci
Leila Chiavacci
The inappropriate use of antimicrobials has resulted in the selection of resistant strains. Thus, a great number of studies have focused on the investigation of new antimicrobial agents. The use of zinc oxide nanoparticles (ZnO NPs) to optimise the fight against microbial resistance has been receiving increased attention due to the non-specific activity of inorganic antimicrobial agents. The small particle size and the high surface area of ZnO NPs can enhance antimicrobial activity, causing an improvement in surface reactivity. In addition, surface modifiers covering ZnO NPs can play a role in mediating antimicrobial activity since the surface properties of nanomaterials alter their interactions with cells; this may interfere with the antimicrobial effect of ZnO NPs. The possibility of using surface modifiers with groups toxic to microorganisms can improve the antimicrobial activity of ZnO NPs. Understanding the exact toxicity mechanisms is crucial to elucidating the antimicrobial activity of ZnO NPs in bacteria and fungi. Therefore, this review aims to describe the mechanisms of ZnO NPs toxicity against fungi and bacteria and how the different structural and physical-chemical characteristics of ZnO NPs can interfere in their antimicrobial activity.

1 May 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Bruna Lallo da SilvaBruna Lallo da Silva
Bruna Lallo da Silva
BCBruno Caetano
Bruno Caetano
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
RPRosemeire Pietro
Rosemeire Pietro
LCLeila Chiavacci
Leila Chiavacci

1 July 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
EMEloisa Berbel Manaia
Eloisa Berbel Manaia
Marina Paiva AbuçafyMarina Paiva Abuçafy
Marina Paiva Abuçafy
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
Bruna Lallo da SilvaBruna Lallo da Silva
Bruna Lallo da Silva
João Augusto Oshiro-JúniorJoão Augusto Oshiro-Júnior
João Augusto Oshiro-Júnior
LCLeila Chiavacci
Leila Chiavacci
Pharmaceutical design has enabled important advances in the prevention, treatment, and diagnosis of diseases. The use of nanotechnology to optimize the delivery of drugs and diagnostic molecules is increasingly receiving attention due to the enhanced efficiency provided by these systems. Understanding the structures of nanocarriers is crucial in elucidating their physical and chemical properties, which greatly influence their behavior in the body at both the molecular and systemic levels. This review was conducted to describe the principles and characteristics of techniques commonly used to elucidate the structures of nanocarriers, with consideration of their size, morphology, surface charge, porosity, crystalline arrangement, and phase. These techniques include X-ray diffraction, small-angle X-ray scattering, dynamic light scattering, zeta potential, polarized light microscopy, transmission electron microscopy, scanning electron microcopy, and porosimetry. Moreover, we describe some of the commonly used nanocarriers (liquid crystals, metal–organic frameworks, silica nanospheres, liposomes, solid lipid nanoparticles, and micelles) and the main aspects of their structures.

1 June 2018 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Marina Paiva AbuçafyMarina Paiva Abuçafy
Marina Paiva Abuçafy
BCBruno Caetano
Bruno Caetano
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
ASAline M. Do Santos
Aline M. Do Santos
LCLeila Chiavacci
Leila Chiavacci

29 September 2017 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
GPGuilherme Pacheco
Guilherme Pacheco
CMCarolina Véspoli de Mello
Carolina Véspoli de Mello
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
VIVera Lucia Borges Isaac
Vera Lucia Borges Isaac
SRSidney José Lima Ribeiro
Sidney José Lima Ribeiro
ETEliane Trovatti
Eliane Trovatti

1 February 2016 in Industrial Crops and Products
Verified
Journal Article
Closed access
Joana MartoJoana Marto
Joana Marto
Luis Pleno GouveiaLuis Pleno Gouveia
Luis Pleno Gouveia
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
APAlexandre Paiva
Alexandre Paiva
VIV. Isaac
V. Isaac
Helena M RibeiroHelena M Ribeiro
Helena M Ribeiro